Skip to content
  • IFPMA Twitter
  • IFPMA LinkedIn
  • IFPMA Youtube
  • IFPMA Slideshare
  • IFPMA Flickr
  • IFPMA RSS
IFPMA
  • Who We Are
    • IFPMA in Brief
    • Our Governance and Leadership
    • Our Membership
      • Full Members
        • Associations
        • Companies
      • Affiliate Members
    • Our Experts
    • Join Us
  • Topics
  • News Center
    • News Releases
    • Blog
      • Global Health Matters
      • Science Matters
      • DG’s Column
      • Contributors
    • Statements
    • Latest News from Our Members
  • Resources
    • Publications
      • News Releases
      • Statements
      • Position Papers
      • Publications
      • External Studies
      • Infographics
      • Event Highlights
    • Multimedia
      • Interviews
      • Podcasts
      • Videos
      • Photos
      • Slides
    • IFPMA Interactive Platforms
      • IFPMA COVID-19 Hub
      • Global Health Progress
      • 50 Years of Global Health Progress
  • Events
    • Upcoming IFPMA Events
      • Geneva Pharma Forums
      • Assemblies
      • Other IFPMA Events
      • IFPMA in External Events
      • IFPMA Press Briefings
    • Past IFPMA Events
      • Geneva Pharma Forums
      • Assemblies
      • Other IFPMA Events
      • IFPMA in External Events
      • IFPMA Press Briefings
  • Partners
  • BCR
  • Inventing Medicines and Vaccines
  • Strengthening Regulatory Systems
  • Ethics and Business Integrity
  • Boosting Innovation and Access
  • Tackling Global health challenges
Economic footprint IP Sustainable innovation Value of innovation

spotlight

Value of innovation

Inventing Medicines and Vaccines
African Medicines Agency Biosimilars Biotherapeutic medicines Falsified medicines Import testing Pharmacovigiliance Quality, safety, and efficacy Regulatory conferences Regulatory system strengthening / Harmonization Supply chain The Africa Regulatory Network (ARN) The ARN: Le réseau africain de réglementation pharmaceutique

spotlight

Pharmacovigiliance

Strengthening Regulatory Systems
IFPMA Code of Practice (2019) Our Ethos Code eLearning Tool IFPMA Notes for Guidance IFPMA Complaint Operating Procedure How to File a Code Complaint Complaint Submission Form Cases Business Ethics for APEC SMEs Initiative Consensus Framework for Ethical Collaboration

spotlight

IFPMA Code of Practice (2019)

Ethics and Business Integrity
Access to medicines Health technology assessment IP Trade

spotlight

Access to medicines

Boosting Innovation and Access
Ageing Antimicrobial resistance Cancer Child and maternal health Diabetes Do you mind? campaign Ebola Falsified medicines Health partnerships HIV/AIDS Humanitarian and disaster relief aid Influenza vaccine Malaria Mental and neurological disorders Neglected tropical diseases Non-communicable diseases Novel Coronavirus (COVID-19) Pandemic influenza preparedness Psoriasis Public health implications of the implementation of the Nagoya Protocol Rare diseases Seasonal influenza Supply chain Sustainable development goals Tuberculosis Universal Health Coverage Vaccines innovation Vaccines protect communities Vaccines sustainability Value of immunization Viral hepatitis Workplace wellness Zika Virus

spotlight

Universal Health Coverage

Tackling Global health challenges
  • Home
  • >
  • Resources
  • >
  • Position Papers
  • >
  • Global Principles on Incentivizing Antibiotic R&D

Global Principles on Incentivizing Antibiotic R&D

Published on: 15 February 2021

Downloads

» IFPMA Global Principles on Incentivizing Antibiotic R&D
» IFPMA_Global_Principles_on_Incentivizing_Antibiotic_R&D_Appendix

Resources

Message from Thomas Cueni at AMR Action Fund launch event in Tokyo on 10 July 2020 (Video)
Videos

Videos

Message from Thomas Cueni at AMR Action Fund launch event in Tokyo on 10 July 2020 (Video)

Launch Event 9 July | New initiative takes on the antibiotic innovation challenge (Video)
Videos

Videos

Launch Event 9 July | New initiative takes on the antibiotic innovation challenge (Video)

AMR Action Fund launch event in Washington DC on 9 July 2020 (Video)
Videos

Videos

AMR Action Fund launch event in Washington DC on 9 July 2020 (Video)

Related Blog Entries

2020: A game-changing year for AMR?

2020: A game-changing year for AMR?

Creating a New Generation of Antibiotics webinar – opportunity to explain how pharma has stepped to the plate

Creating a New Generation of Antibiotics webinar – opportunity to explain how pharma has stepped to the plate

Antimicrobial resistance: A ticking time bomb

Antimicrobial resistance: A ticking time bomb

Related Links

AMR Action Fund
AMR Industry Alliance

Related Topics

Antimicrobial resistance

Tags

  • AMR
  • Antibiotics Pipeline
  • antimicrobial resistance
  • incentives
IFPMA

Chemin des Mines 9
1202 Geneva
Switzerland

+41 22 338 32 00
info@ifpma.org

  • File a Code Complaint
  • Privacy Policy
  • Terms of Use
  • Access to Our Extranet
  • Careers
  • Contact Us
  • IFPMA Twitter
  • IFPMA LinkedIn
  • IFPMA Youtube
  • IFPMA Slideshare
  • IFPMA Flickr
  • IFPMA RSS
Designed and Produced by ACW
^ Back to Top
Cookie Policy
This website uses cookies to ensure you get the best experience on our website. Learn More
Decline Allow Cookies